[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PMN":3,"homepage-market-summary":31,"stock-news-PMN":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PMN","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"ProMIS Neurosciences Inc. Common Shares (ON)","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.","11","Toronto, A6",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},9.12,9.17,9.5199,9.01,9.21,-0.09,-0.98,25102.71107,346,9.2095,27.4,6.27,80378.97690353786,13.5,4967,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},9,[176,182,188,194,199,205,211,217,222],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Alzheimer’s drug data are expected in Q1 2027. ProMIS hires a former Biogen leader to shape market plans. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPNUxQcEV3RkpIQmxIM0RyM1dwcnJSODRaQjd2X081V3F2U2oyZ3ZqVkNKQkhoMjJoNDh5Ulh4M2lLS0pjZlBQWmFVUkg3V1RoWTc0eU85aHFEdmpLcTYyNlp1QUZtMGtqTmdaY1d6QXUyYVdGZFZPNERLR20za25GU1pXZHZDYWVGdUZGMlFtSzUyOHdDNE9nMldyUUlBT0VpdTJYR0xUd0xPVnFwdkxRaVdnREI0SlI5cU9fYm13UQ?oc=5","Tue, 06 Oct 2026 11:05:00 GMT","Alzheimer’s drug data are expected in Q1 2027. ProMIS hires a former Biogen leader to shape market plans. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"(PMN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPM19GbW5GaDE5bWd5cGFFcncxdG1IM1hrcGIwcExXa004S05mbGJ4amN6RlNPclRTR29mZFhqSEstUlhmZDdpRy1kelRPMmZaYXZKcGdFOWpFVmJ3MERQVTBMdWZWWGx5VDBGNGRFV1RBa0FGRl9aU1kzdVFYY2VWTmNVUGU0TE1tWkR6WXR3c1ltbGRiMFN2b3A4UGN6cHNLZDEyakxWVzZiMzF0c3FVSkVYdVVyMmR6RmdLaHdacHlWRlI3ZkpaTQ?oc=5","Mon, 28 Sep 2026 06:04:02 GMT","(PMN) Price Dynamics and Execution-Aware Positioning Stock Traders Daily","Stock Traders Daily",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Climb Bio (NasdaqGM:CLYM) Stock Forecast & Analyst Predictions - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijAFBVV95cUxQTHd3d0cyRUlTaXFMVmNUdWExQUNMbjZicUlvZDFDRmt6UXMwUkZzaEdfZTl5UktVSVFsM25fR205RVhNbjh2a0ZDd3p1S2hlVWdXYjJiMGh1TWczTDZnUlZ1Z0dXZzVXTkVEazk3MjFDVXRZVGVSNHZBczVrYkNmVWJoN2dMZ0I0TEZpQg?oc=5","Fri, 02 Oct 2026 07:00:00 GMT","Climb Bio (NasdaqGM:CLYM) Stock Forecast & Analyst Predictions Simply Wall Street","Simply Wall Street",{"title":195,"link":196,"pubDate":197,"description":198,"source":181},"80,000 stock options go to Ivana Rubino at ProMIS Neurosciences (PMN), exercisable at $9.37. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxNY1lmOU5mT1ZGb2pVUjlJVmx6eFEydThhZEJ2bFlQSkI4YllPbkxGU0FJX09iY0JObEt2eUs3VmNrc05IeVpyVW5MazEyanROV3JheWx6Z3IxSjN4bGQydEhPSzVIc3RHX0pJcDNpLTBtUGlmNjRkS25Rc2dKNkw2WjRRRkl3MFM2OFFsV3JQMW5pYVNRRUlqRThfd2hWaTB5REV4X3lhcmpMV3U0QnlLZE5VeXM5V2VsM1E?oc=5","Tue, 06 Oct 2026 21:25:21 GMT","80,000 stock options go to Ivana Rubino at ProMIS Neurosciences (PMN), exercisable at $9.37. Stock Titan",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"ProMIS Neurosciences Inc. (NASDAQ: PMN) Share Price, PMN Stock News, PMN Share Price & Updates - kalkine.ca","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiT0FVX3lxTFBScF9NMy0zZWxWOC15NlpMZ3AtamZIMW5xbV8yaUcybU9Ca3NadVE3aFZib1E0OEZiQVFhNHE0WHExdV9sVENhNGVpWkoxajQ?oc=5","Fri, 25 Sep 2026 20:00:00 GMT","ProMIS Neurosciences Inc. (NASDAQ: PMN) Share Price, PMN Stock News, PMN Share Price & Updates kalkine.ca","kalkine.ca",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"CABA,SKWD,PFX,FFIN,ELUT,HYPD,ZBIO,BLCO,ALT,TSLX,ENTX,PMN,TBBK,BLIN,SSP,PCF,GAIA,SPMC,GEF-B,APCX,IRIX,RAL,RNXT | Stock Prices | Quote Comparison - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3wFBVV95cUxOSXc4RUFjel84LTVKR0E2UElWSFFCeTdDVjNzMVRQYVpTNnZzMVJzNk83UnRLNHRLSlNibHFRSk11eENiWWhfQnpyT050Tjh3S3ZrSWlHSzhoU3ZXZmtSZFlZZEZaSi1tLThCdzhVNWZWQ3M5aXFPdjVLOERFZjlYOUlNUE16UXJqN0tQMndXT001SENXV2VPazF6QllOX0lZMzJSdWY4Y2tMYVNpNEF2THYySXFGT3lwdXZwa29IZVVsNE95WGhaSGF5YmV0MnFoemVTT0FXRm8yOXA4T2g0?oc=5","Sat, 03 Oct 2026 20:09:19 GMT","CABA,SKWD,PFX,FFIN,ELUT,HYPD,ZBIO,BLCO,ALT,TSLX,ENTX,PMN,TBBK,BLIN,SSP,PCF,GAIA,SPMC,GEF-B,APCX,IRIX,RAL,RNXT | Stock Prices | Quote Comparison Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Sangamo Therapeutics (SGMO) Stock Chart and Price History 2026 - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiYkFVX3lxTE5rS2VUMGt6S18xbW5YT2pyeUpZVDVkTHZVeFpuR3R4S0w4UTg5RG1pcHBCWjMwNGRrSXlfeWFBVGx0bWtITjlLQVlYcDhobXdfY1R2MmJiVHh0N2RXM3R4NE9n?oc=5","Mon, 05 Oct 2026 07:00:00 GMT","Sangamo Therapeutics (SGMO) Stock Chart and Price History 2026 MarketBeat","MarketBeat",{"title":218,"link":219,"pubDate":220,"description":221,"source":181},"[Form 3] ProMIS Neurosciences Inc. Initial Statement of Beneficial Ownership - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxOakNIdWNGcWlkN3FzN3hvX3N6ZmJRWlBFMmFHVmFCOFF1Ui1vMGxodmtsOVVTajREcWNlMEdsbUxLUGtNb0xJbjZVRGxjdmw4cXZyNHlaeXRhaDBTUjY4UEd2V0F6ZjBmbU8wbU51c0JzTC1MVWQzNGVxOVYtRDBPTnRpalhsdk9HNVo0Q1prOWNucE42VU4wbjdzQmtFSmZFX1FIMWZjV2dWRjlkYjBYOEp0MDQ5ZUpJZDJad0FfWkJOOEtmNXdMdzln?oc=5","Tue, 06 Oct 2026 22:01:24 GMT","[Form 3] ProMIS Neurosciences Inc. Initial Statement of Beneficial Ownership Stock Titan",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"LexinFintech (LX) Edges Lower to $0.74 as Shares Sit Between Key Technical Levels - Long Short Pair - https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPVEJobEs0QjF6eGpNR0lKMU9lTkhzcmVYTWhYX0lTcUx3cnJBemhOVkRwZUpzQm4yZFNPRk1fTWJDTFhzSmRoMDVPV2dZTmd1RFdYdE0tNU53dDBVLTMyczdQMS1jb0N4REs0bzc1R2NRa0lmeUYtWGUtWU10akpxVVdyeHpsaHRIRW1MOTlIbS1iZjA0Y2JaeURFN1hyUE9tS3VNSTR6NEtlZ3FZOWFHQjJFQjdTWENGR3hr?oc=5","Mon, 28 Sep 2026 07:00:00 GMT","LexinFintech (LX) Edges Lower to $0.74 as Shares Sit Between Key Technical Levels - Long Short Pair https:\u002F\u002Fwww.dars.gov.et\u002F","https:\u002F\u002Fwww.dars.gov.et\u002F"]